[ Price : $8.95]
FDA principal deputy commissioner Joshua Sharfstein says that without the ability to impose a REMS, FDA probably would have had to...[ Price : $8.95]
FDA says it wants more data on a new extended-release formulation of Johnson & Johnsons tapendatol[ Price : $8.95]
FDA says it has reached agreement with Onconova Therapeutics on an SPA for a Phase 3 trial of Estybon in patients with myeldosplas...[ Price : $8.95]
Synthes and its Norian subsidiary agree to plead guilty to federal charges stemming from the companies clinical trials of a Norian...[ Price : $8.95]
FDA says it is making significant progress with its FY 2009 drug user fee performance after falling behind in FY 2008 due to addit...[ Price : $8.95]
FDA approves a Mylan Pharmaceuticals ANDA for a generic copy of GlaxoSmithKline's antidepressant Wellbutrin XL.[ Price : $8.95]
Federal Register Notice: FDA releases an enforcement action plan for promotion and advertising restrictions on menthol and other c...[ Price : $8.95]
Federal Register Notice: FDA announces a Web site location where it will post a list of guidance documents CDRH is considering for...